In this episode, Scott Becker explores Carvanas rapid rebound from its near bankruptcy in 2022.

In this episode, Scott Becker breaks down the current trends, risks, and opportunities in private equity investing in healthcare.

In this episode, Scott Becker reviews the Fed’s recent 25 basis point rate move.

In this episode, Scott Becker breaks down Lululemons sharp decline in performance, the exit of CEO Calvin McDonald, and ongoing struggles with U.S. sales and merchandising.

In this episode, David Pivnick, Partner at McGuireWoods LLP, discusses how he assesses talent, the importance of work ethic and leadership, and how to coach high performers while managing team dynamics.

In this episode, Scott Becker breaks down Oracles sharp stock drop after a year of soaring AI driven gains.

In this episode, Amber Walsh of McGuireWoods, breaks down the current healthcare private equity landscape, including deal activity, value creation strategies, clinician alignment, and more.

In this episode, Scott Becker discusses SpaceX’s potential trillion and a half dollar IPO and why its massive valuation is capturing market attention.

In this episode, Scott Becker highlights the importance of fire starters, the high-drive innovators whose energy and focus push new ideas and companies off the ground.

In this episode, Scott Becker breaks down the weeks top stories, including the bidding battle for Warner Brothers Discovery, IBMs Confluent acquisition, expected Fed rate cuts, Medlines $55 billion IPO, and Magnums $9 billion valuation as it spins out